China Pharmaceutical Investment halfway through Beijing Strong Biotechnologies share increase plan

China Pharmaceutical Investment, a shareholder holding over 5% of Beijing Strong Biotechnologies, has reached the halfway point in its plan to increase its stake. The plan, which began on June 23, 2025, and is set to end on December 22, 2025, aims to increase shareholdings by at least RMB 30,000,000 using self-owned funds.

As of September 22, 2025, China Pharmaceutical Investment acquired 2,621,000 shares through concentrated bidding, representing 0.45% of the company's current voting shares. The total value of these increased holdings amounts to RMB 35,696,359. Prior to the increase, China Pharmaceutical Investment held 18.04% of voting shares, which has now risen to 18.55%.

Beijing Strong Biotechnologies cautions investors about the inherent risks associated with market fluctuations that could impact the remainder of the plan. However, the current increase aligns with relevant regulations and will not alter the company's control or its compliance with listing requirements.